Literature DB >> 18765591

Effects of method of presynchronization and source of selenium on uterine health and reproduction in dairy cows.

H M Rutigliano1, F S Lima, R L A Cerri, L F Greco, J M Vilela, V Magalhães, F T Silvestre, W W Thatcher, J E P Santos.   

Abstract

The objectives of this study were to evaluate the effects of method of presynchronization and source of supplemental Se on uterine health and reproductive performance of lactating dairy cows. Holstein cows (n = 512) were assigned randomly to 2 methods of presynchronization, Presynch (2 PGF(2a) given 14 d apart) or CIDR-PS (controlled internal drug releasing inserted for 7 d with an injection of PGF(2a) at removal) and 2 sources of Se, sodium selenite (SS) or selenized yeast (SY) supplemented at 0.3 mg/kg from 25 d before calving to 80 d in milk (DIM) arranged in a 2 x 2 factorial. Cows were inseminated following the Ovsynch protocol (d 0 GnRH, d 7 PGF(2a), d 9 GnRH, timed artificial insemination (AI) 12 h after the final GnRH) starting at 12 and 3 d after Presynch and CIDR-PS, respectively. Cows were diagnosed for pregnancy at 28, 42, and 56 d after AI. Source of Se did not influence uterine health and resumption of cyclicity, but fewer CIDR-PS than Presynch cows were cyclic at the beginning of the Ovsynch, although differences in the proportion cyclic may have been caused by the timing when corpus luteum evaluations were performed in the different pre-synchronization treatments. Ovulatory responses were not influenced by source of Se. However, the CIDR-PS increased ovulation to the first GnRH, double ovulation to the final GnRH, and size of ovulatory follicle at PGF(2a) and final GnRH of the Ovsynch, but did not influence ovulation at the final GnRH of the Ovsynch. Concentrations of estradiol during the Ovsynch increased with follicle diameter and were greater for cows receiving CIDR-PS than Presynch, but they were not influenced by source of Se. Pregnancy per AI on d 28 (32.7%), 42 (28.5%), and 56 (25.9%) after AI, and pregnancy loss (20.5%) from 28 to 56 d were not influenced by source of Se or method of presynchronization. Although cows receiving CIDR-PS had an increased incidence of ovulation to the first GnRH (73.2 vs. 57.8%) and double ovulation to the final GnRH of the Ovsynch (18.7 vs. 9.0%), both of which enhanced pregnancy, the CIDR-PS protocol did not improve pregnancy per AI or reduce pregnancy loss compared with presynchronization with PGF(2a) alone.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18765591     DOI: 10.3168/jds.2008-1005

Source DB:  PubMed          Journal:  J Dairy Sci        ISSN: 0022-0302            Impact factor:   4.034


  5 in total

1.  Non-infectious causes that increase early and mid-to-late pregnancy loss rates in a crossbreed dairy herd.

Authors:  Fransergio Souza; Luisa Cunha Carneiro; João Cesar; Ricarda Maria Dos Santos
Journal:  Trop Anim Health Prod       Date:  2018-11-10       Impact factor: 1.559

2.  Comparative evaluation of hormonal protocol on the performance of crossbred cattle.

Authors:  J K Sahoo; S K Das; K Sethy; S K Mishra; R K Swain; P C Mishra; S P Sahoo
Journal:  Trop Anim Health Prod       Date:  2016-11-25       Impact factor: 1.559

Review 3.  Update on Multiple Ovulations in Dairy Cattle.

Authors:  Kira Macmillan; John P Kastelic; Marcos G Colazo
Journal:  Animals (Basel)       Date:  2018-04-24       Impact factor: 2.752

4.  Mitochondrial-related consequences of heat stress exposure during bovine oocyte maturation persist in early embryo development.

Authors:  Rebecca R Payton; Louisa A Rispoli; Kimberly A Nagle; Cedric Gondro; Arnold M Saxton; Brynn H Voy; J Lannett Edwards
Journal:  J Reprod Dev       Date:  2018-03-18       Impact factor: 2.214

5.  Heat-induced hyperthermia impacts the follicular fluid proteome of the periovulatory follicle in lactating dairy cows.

Authors:  Louisa A Rispoli; J Lannett Edwards; Ky G Pohler; Stephen Russell; Richard I Somiari; Rebecca R Payton; F Neal Schrick
Journal:  PLoS One       Date:  2019-12-30       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.